# Safety Study of Latanoprost Slow Release Insert

> **NCT01180062** · PHASE1 · TERMINATED · sponsor: **Daniel Moore** · enrollment: 12 (actual)

## Conditions studied

- Primary Open Angle Glaucoma (POAG)
- Ocular Hypertension (OHT)

## Interventions

- **DRUG:** Latanoprost
- **DRUG:** Arm 2
- **DRUG:** Latanoprost SR insert

## Key facts

- **NCT ID:** NCT01180062
- **Lead sponsor:** Daniel Moore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study terminated early due to manufacturer not replenishing study site supply of inserts, despite repeated requests for more inserts.
- **Last updated:** 2014-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01180062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01180062, "Safety Study of Latanoprost Slow Release Insert". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01180062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*